Company Information
USD
0.69
- (1.5%)
NASDAQ:SNES, SENESTECH, INC.
Industry: Specialty Chemicals
End of Day: 17 May 2024 GMT-4
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
Address
23460 N 19th Avenue
Suite 110
Website
Classification
Sector
Basic Materials
Industry Group
Chemicals
Industry
Specialty Chemicals
Key Executives
Mr. Matthew K. Szot
Director/Vice Chairman of the Board
Mr. Thomas C. Chesterman
Assistant Secretary/CFO/Chief Accounting Officer/Executive VP/Treasurer
Mr. Jake Leach
Director
Dr. Jamie Bechtel Morrison, J.D.,PhD
Chairman of the Board/Director
Ms. Delphine Francois Chiavarini
Director
Mr. Phillip Nicholas Grandinetti
Director
Mr. Joel Fruendt
CEO/Director/President
Ms. Kim Patrice Wolin
Executive VP, Divisional/Secretary
Ownership
Institution Holdings
Intracoastal Capital LLC
154,028 (5.196%)
JPMorgan Chase & Co
16,971 (0.330%)
Tower Research Capital LLC
6,999 (0.136%)
UBS Group AG
4,140 (0.080%)
Fidelity Management & Research Company LLC
1,847 (0.036%)
Bank of America Corp
1,000 (0.019%)
State Street Global Advisors
236 (0.005%)
Northern Trust Investments Inc
31 (0.001%)
Northern Trust Asset Management
30 (0.001%)
FMR Inc
29 (0.001%)
Funds Holdings
NT DJ US Complt Ttl Stk Mkt Idx Eq Strat
30 (0.001%)
NT Ext Equity Market Index Fund - L
30 (0.001%)
SSgA U.S. Total Market Index Fund
30 (0.001%)
Make Smart Investment Choices